1–2 of 2 results for IRX-101
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 inReducing Post-Intravitreal Injection Pain and Corneal Toxicity: RELIEF Trial Results
Karen M Wai, MD
Annual Meeting Talks
2025
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Toxicity: RELIEF Trial Results
STEPHEN J SMITH, MD
Updates from the Field